Archive | Diabetes RSS feed for this section

In case of an emergency

Hyperglycaemic emergencies According to the 2017 Journal of Endocrinology, Metabolism and Diabetes of South Africa guidelines, hyperglycaemic emergencies, diabetic ketoacidosis (DKA) and hyperglycaemic hyperosmolar state (HHS), should be suspected whenever patients have hyperglycaemia, especially if they are systematically unwell or are known to have diabetes. “Significant morbidity and mortality are attached to these conditions and […]

Read full story · Comments { 0 }

Achieving glycaemic control

Diabetes is South Africa’s second biggest killer but there is a critical lack of consensus among experts and policymakers about how this growing epidemic should be tackled. (more…)

Read full story · Comments { 0 }

The efficacy and benefits of GLP-1 and basal insulin

According to the International Diabetes Federation, it is estimated that an average of 387 million people worldwide live with diabetes, with an average of 21 million people from Africa suffering from the disease. Further, it is estimated that 77% of people with diabetes live in low- to middle-income countries. Type 2 diabetes is a progressive […]

Read full story · Comments { 0 }

The power of 8

A long-term Danish follow-up study published in Diabetologia, the journal of the European Association for the Study of Diabetes, shows that intensified and multifaceted treatment of patients with type 2 diabetes (T2DM) and a common complication microalbuminuria extends median lifetime by eight years. (more…)

Read full story · Comments { 0 }

Monitoring glycaemic control

Glycated haemoglobin (A1C) is a reliable estimate of mean plasma glucose (PG) levels over the previous three to four months for most individuals. (more…)

Read full story · Comments { 0 }

New class of diabetes treatment for South Africa

Type 2 diabetes (T2D) often becomes more difficult to manage over time, and many people require add-on medication. Empagliflozin, a once-daily oral treatment for T2D among adults, is in the final stages of regulatory approval in South Africa. The product is licensed and introduced by Boehringer Ingelheim in several other markets, including the US, European […]

Read full story · Comments { 0 }

Basal-plus stepwise treatment regimen

Type 2 diabetes mellitus (T2DM) is a chronic disease characterised by a progressive decline of β-cell function and/or mass in the presence of insulin resistance that requires timely treatment intensification to achieve and maintain optimum metabolic control. (more…)

Read full story · Comments { 0 }

Predicting the bounce of the ball

Comparing SA’s approach to diabetes care with the unpredictable bounce of a rugby ball, Prof Jeffrey Wing, Chief Specialist in the Department of Internal Medicine, Johannesburg Hospital and University of the Witwatersrand, said the country urgently needs a new strategy aimed at predicting the bounce of the ball. (more…)

Read full story · Comments { 0 }

Better connected for better decisions

First Results from the Accrues study The efficacy of diabetes management software was recently shown in the Accu–Chek® Connect Reports Utility and Efficiency Study (ACCRUES)1. The researchers found that ‘technology advancements that provide seamless and wireless patient data in a format that facilitates accurate and efficient identification of glucose patterns likely enhance the ability of […]

Read full story · Comments { 0 }

Metformin: An oldie, but goodie

The discovery of metformin began with the synthesis of galegine-like compounds derived from Gallega officinalis, a plant traditionally employed in Europe as a drug for diabetes treatment for centuries. (more…)

Read full story · Comments { 0 }

FreeStyle LibrePro launched in SA

A ‘game changer in diabetic care’ is how Dr Larry Distiller described Abbott’s new FreeStyle Libre Pro. This innovative clinician’s glucose assessment tool was launched in SA last month. (more…)

Read full story · Comments { 1 }